Your browser doesn't support javascript.
loading
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia.
Mussai, Francis; Wheat, Rachel; Sarrou, Evgenia; Booth, Sarah; Stavrou, Victoria; Fultang, Livingstone; Perry, Tracey; Kearns, Pamela; Cheng, Paul; Keeshan, Karen; Craddock, Charles; De Santo, Carmela.
Affiliation
  • Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Wheat R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Sarrou E; Paul O'Gorman Leukaemia Research Centre, College of Medicine, Veterinary Life Sciences, Institute of Cancer Sciences, University of Glasgow, United Kingdom.
  • Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Perry T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Kearns P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Cheng P; Bio-cancer Treatment International Ltd, Hong Kong.
  • Keeshan K; Paul O'Gorman Leukaemia Research Centre, College of Medicine, Veterinary Life Sciences, Institute of Cancer Sciences, University of Glasgow, United Kingdom.
  • Craddock C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
  • De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Int J Cancer ; 145(8): 2201-2208, 2019 10 15.
Article in En | MEDLINE | ID: mdl-30485425

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arginase / Arginine / Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid / Antigens, Neoplasm Type of study: Clinical_trials Limits: Humans Language: En Journal: Int J Cancer Year: 2019 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arginase / Arginine / Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid / Antigens, Neoplasm Type of study: Clinical_trials Limits: Humans Language: En Journal: Int J Cancer Year: 2019 Type: Article Affiliation country: United kingdom